Blogs
INSIGHTS & ARTICLES
DnXT Blog
Expert insights on regulatory operations, eCTD publishing, and digital transformation in life sciences.
The Real Cost of Enterprise RIM: What Vendors Won’t Show You
Enterprise RIM pricing goes far beyond the license fee. Here's the full cost picture for growing biotech — and what to look for in alternatives.
eCTD 4.0: What Senior Regulatory Leaders Need to Know Now
eCTD 4.0 moves to HL7 RPS — a fundamental shift. Here's what regulatory teams at emerging biotech need to prepare for and what to ask your vendor.
Why We’re Not Veeva (And Why That’s the Point)
Enterprise RIM platforms are overbuilt and overpriced for growing biotech. DnXT is cloud-native eCTD publishing built for the companies the big guys ignore.
Bulletproof AI Security: How DNXT’s Self-Hosted LLM Protects Your Regulatory Data from External Breaches
In pharmaceutical document management, data security isn’t just important—it’s mission-critical. When sensitive regulatory documents contain proprietary formulations, clinical trial data, and submission strategies worth millions, the last thing you want...
How Remote Regulatory Teams Drive 40% Faster Drug Approvals While Cutting Operational Costs
The Remote Revolution in Pharmaceutical Regulatory Affairs The pharmaceutical industry’s shift to distributed regulatory teams isn’t just a trend—it’s a strategic imperative. Companies managing remote regulatory operations are experiencing faster...
Why Smart Pharma Companies Are Winning the Regulatory Technology Investment Battle
The CFO Question Every Regulatory Leader Faces “How do you justify spending millions on regulatory technology when budgets are already stretched thin?” If you’ve been in pharma regulatory for more...
Stop Regulatory Document Chaos: Master Version Control for Pharma Compliance
The Hidden Cost of Document Confusion Picture this: Your regulatory team is preparing for a critical FDA submission when someone discovers they’ve been working on an outdated document version for...
How to Master Global Regulatory Submissions Across Multiple Markets Without Breaking Your Budget
The Global Regulatory Challenge That’s Costing You Time and Money Your breakthrough pharmaceutical product is ready for the world, but navigating simultaneous submissions to the FDA, EMA, Health Canada, and...
Master Your eCTD 4.0 Migration: The Complete Strategic Guide for Regulatory Success
The Clock Is Ticking: Why eCTD 4.0 Migration Can’t Wait Pharmaceutical companies worldwide face a critical transition that could make or break their regulatory submission success. The migration from eCTD...
Transform Your Regulatory Team Performance: Leadership Strategies That Cut Burnout and Boost Efficiency by 40%
The Hidden Crisis in Regulatory Operations Regulatory operations directors face an impossible equation: increasing submission volumes, tighter deadlines, and mounting compliance pressures—all while working with the same stretched teams. The...
The Hidden Cost of eCTD Submission Errors: How Automation Saves Millions in Regulatory Delays
Every Rejection Costs More Than You Think A single eCTD submission error can cascade into months of delays, regulatory scrutiny, and millions in lost revenue. For pharmaceutical companies racing to...
Master FDA Audit Preparation: Your Complete Guide to Regulatory Compliance Success
FDA audits can make or break pharmaceutical companies. When regulatory inspectors arrive at your facility, the difference between a successful audit and costly citations often comes down to one thing:...
